Evidence map›Paper›PMID 9822738›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1998

Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis.

S Bursztajn, R DeSouza, D L McPhie, S A Berman, J Shioi, N K Robakis, R L Neve

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  8. Article
  9. Review
  10. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2000
    Article
  16. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  17. Article
  18. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
  19. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

S BursztajnDepartment of Psychiatry and Program in Neuroscience, Harvard Medical School, Belmont, Massachusetts 02478, USA. sbursz@lsumc.edu
R DeSouza
D L McPhie
S A Berman
J Shioi
N K Robakis
R L Neve
Harvard University · USIcahn School of Medicine at Mount Sinai · USMassachusetts Institute of Technology · USMcLean Hospital · US

Funding

STRUCTURE &EXPRESSION OF THE B-PROTEIN-PRECURSOR GENER01AG008200 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 1988 to 2017
$5.6M
Effects of PS1FAD mutations on PS1-NMDAR association, necroptosis and electrophysiology.RF1AG008200 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROBAKIS, NIKOLAOS K · 2018 to 2018
$2.8M
MOLECULAR BIOLOGY OF ALZHEIMER DISEASE NEURODEGENERATIONR01AG012954 · NIA · MC LEAN HOSPITAL (BELMONT, MA) · PI NEVE, RACHAEL LEE · 1994 to 2004
$1.3M
NIA NIH HHS AG08200NIA NIH HHS AG12954NIA NIH HHS R01 AG008200NIA NIH HHS R01 AG012954NIA NIH HHS RF1 AG008200
6 · The paper itself

Abstract

Programmed cell death, or apoptosis, has been implicated in Alzheimer's disease (AD). DNA damage was assessed in primary cortical neurons infected with herpes simplex virus (HSV) vectors expressing the familial Alzheimer's disease (FAD) gene presenilin-1 (PS-1) or an FAD mutant of this gene, A246E. After infection, immunoreactivity for PS-1 was shown to be enhanced in infected cells. The infected cells exhibited no cytotoxicity, as evaluated by trypan blue exclusion and mitochondrial function assays. Quantitative analysis of cells that were immunohistochemically labeled using a Klenow DNA fragmentation assay or the TUNEL method revealed no enhancement of apoptosis in PS-1-infected cells. This result was confirmed using assays for chromatin condensation and for DNA fragmentation. Expression of PS-1 protected against induction of apoptosis in the cortical neurons by etoposide or staurosporine. The specificity of this phenotype was demonstrated by the fact that cortical cultures infected with recombinant HSV vectors expressing the amyloid precursor protein (APP-695) showed, in contrast, a significant increase in the number of apoptotic cells and an increase in DNA fragmentation for all parameters tested. Our results indicate that overexpression of wild-type or A246E mutant PS-1 does not enhance apoptosis in postmitotic cortical cells and suggest that the previously reported enhancement of apoptosis by presenilins may be dependent on cell type.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorApoptosisBisbenzimidazoleCell SurvivalCerebral CortexDNA FragmentationFluorescent DyesGene ExpressionHumansIn Situ Nick-End LabelingMembrane ProteinsMutationNerve DegenerationNeuronsPresenilin-1Amyloid beta-Protein PrecursorBisbenzimidazoleFluorescent DyesMembrane ProteinsPresenilin-1PSEN1 protein, humanRecombinant Proteins

Identifiers

PMID9822738
PMCPMC6793279
OpenAlexW2136825556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.